I remember reading how the patent applies to the pen and not the molecule. Apparently, the production of the hormone itself isnt incredibly tough, its mostly th

I remember reading how the patent applies to the pen and not the molecule. Apparently, the production of the hormone itself isnt incredibly tough, its mostly the pen thats problematic; it is meant to be really easy to apply and thus is hard to produce. But I dont understand why having more competitors trying to replicate your pen would be a bad idea. Those treatments are horribly expensive, so competition is more than welcome imo.